Payer Perceptions of the Inflation Reduction Act
Lumanity convened medical and pharmacy directors from six large national and regional US payers with at least 25% Medicare business to share their perspectives on both the Maximum Fair Price (MFP) drug price negotiation and Part D redesign components of the IRA. Read the six key insights from our panel.
View Aug 28, 2023
Cosmetics Industry Regulatory Updates
The Modernization of Cosmetics Regulation Act was signed into law in December of 2022. Learn about a few new regulatory requirements that need to be addressed by December of 2023.
View Apr 11, 2023